Advanced search
1 file | 1.30 MB Add to list

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age : a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

Author
Organization
Abstract
We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effects on migraine course of exogenous estrogens and progestogens and on possible treatment of headache associated with the use or with the withdrawal of hormones. Overall, quality of current evidence is low. Recommendations are provided for all the compounds with available evidence including the conventional 21/7 combined hormonal contraception, the desogestrel only oral pill, combined oral contraceptives with shortened pill-free interval, combined oral contraceptives with estradiol supplementation during the pill-free interval, extended regimen of combined hormonal contraceptive with pill or patch, combined hormonal contraceptive vaginal ring, transdermal estradiol supplementation with gel, transdermal estradiol supplementation with patch, subcutaneous estrogen implant with cyclical oral progestogen. As the quality of available data is poor, further research is needed on this topic to improve the knowledge about the use of estrogens and progestogens in women with migraine. There is a need for better management of headaches related to the use of hormones or their withdrawal.
Keywords
Migraine, Headache, Estrogens, Progestogens, Hormonal contraceptives, Contraception, COMBINED ORAL-CONTRACEPTIVES, MENSTRUAL MIGRAINE, ONLY CONTRACEPTION, DOUBLE-BLIND, PERCUTANEOUS ESTRADIOL, FREE INTERVAL, YOUNG-WOMEN, LIFE EVENTS, AURA, PREVENTION

Downloads

  • Sacco JHP 2018.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 1.30 MB

Citation

Please use this url to cite or link to this publication:

MLA
Sacco, Simona, Gabriele S Merki-Feld, Karen Lehrmann Ægidius, et al. “Effect of Exogenous Estrogens and Progestogens on the Course of Migraine During Reproductive Age : a Consensus Statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).” JOURNAL OF HEADACHE AND PAIN 19 (2018): n. pag. Print.
APA
Sacco, S., Merki-Feld, G. S., Lehrmann Ægidius, K., Bitzer, J., Canonico, M., Gantenbein, A. R., Kurth, T., et al. (2018). Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age : a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). JOURNAL OF HEADACHE AND PAIN, 19.
Chicago author-date
Sacco, Simona, Gabriele S Merki-Feld, Karen Lehrmann Ægidius, Johannes Bitzer, Marianne Canonico, Andreas R Gantenbein, Tobias Kurth, et al. 2018. “Effect of Exogenous Estrogens and Progestogens on the Course of Migraine During Reproductive Age : a Consensus Statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).” Journal of Headache and Pain 19.
Chicago author-date (all authors)
Sacco, Simona, Gabriele S Merki-Feld, Karen Lehrmann Ægidius, Johannes Bitzer, Marianne Canonico, Andreas R Gantenbein, Tobias Kurth, Christian Lampl, Øjvind Lidegaard, E Anne MacGregor, Antoinette MaassenVanDenBrink, Dimos-Dimitrios Mitsikostas, Rossella Elena Nappi, George Ntaios, Koen Paemeleire, Per Morten Sandset, Gisela Marie Terwindt, Kjersti Grøtta Vetvik, and Paolo Martelletti. 2018. “Effect of Exogenous Estrogens and Progestogens on the Course of Migraine During Reproductive Age : a Consensus Statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).” Journal of Headache and Pain 19.
Vancouver
1.
Sacco S, Merki-Feld GS, Lehrmann Ægidius K, Bitzer J, Canonico M, Gantenbein AR, et al. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age : a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). JOURNAL OF HEADACHE AND PAIN. 2018;19.
IEEE
[1]
S. Sacco et al., “Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age : a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH),” JOURNAL OF HEADACHE AND PAIN, vol. 19, 2018.
@article{8573232,
  abstract     = {We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effects on migraine course of exogenous estrogens and progestogens and on possible treatment of headache associated with the use or with the withdrawal of hormones. Overall, quality of current evidence is low. Recommendations are provided for all the compounds with available evidence including the conventional 21/7 combined hormonal contraception, the desogestrel only oral pill, combined oral contraceptives with shortened pill-free interval, combined oral contraceptives with estradiol supplementation during the pill-free interval, extended regimen of combined hormonal contraceptive with pill or patch, combined hormonal contraceptive vaginal ring, transdermal estradiol supplementation with gel, transdermal estradiol supplementation with patch, subcutaneous estrogen implant with cyclical oral progestogen. As the quality of available data is poor, further research is needed on this topic to improve the knowledge about the use of estrogens and progestogens in women with migraine. There is a need for better management of headaches related to the use of hormones or their withdrawal.},
  articleno    = {76},
  author       = {Sacco, Simona and Merki-Feld, Gabriele S and Lehrmann Ægidius, Karen and Bitzer, Johannes and Canonico, Marianne and Gantenbein, Andreas R and Kurth, Tobias and Lampl, Christian and Lidegaard, Øjvind and MacGregor, E Anne and MaassenVanDenBrink, Antoinette and Mitsikostas, Dimos-Dimitrios and Nappi, Rossella Elena and Ntaios, George and Paemeleire, Koen and Sandset, Per Morten and Terwindt, Gisela Marie and Vetvik, Kjersti Grøtta and Martelletti, Paolo},
  issn         = {1129-2369},
  journal      = {JOURNAL OF HEADACHE AND PAIN},
  keywords     = {Migraine,Headache,Estrogens,Progestogens,Hormonal contraceptives,Contraception,COMBINED ORAL-CONTRACEPTIVES,MENSTRUAL MIGRAINE,ONLY CONTRACEPTION,DOUBLE-BLIND,PERCUTANEOUS ESTRADIOL,FREE INTERVAL,YOUNG-WOMEN,LIFE EVENTS,AURA,PREVENTION},
  language     = {eng},
  pages        = {21},
  title        = {Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age : a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)},
  url          = {http://dx.doi.org/10.1186/s10194-018-0896-5},
  volume       = {19},
  year         = {2018},
}

Altmetric
View in Altmetric
Web of Science
Times cited: